Skip to Content

Yupelri Prices, Coupons and Patient Assistance Programs

Yupelri (revefenacin) is a member of the anticholinergic bronchodilators drug class and is commonly used for COPD, and COPD - Maintenance.

Yupelri Prices

The cost for Yupelri inhalation solution (175 mcg/3 mL) is around $1,190 for a supply of 90 milliliters, depending on the pharmacy you visit. Prices are for cash paying customers only and are not valid with insurance plans.

Yupelri is available as a brand name drug only, a generic version is not yet available. For more information, read about generic Yupelri availability.

This Yupelri price guide is based on using the Drugs.com discount card which is accepted at most U.S. pharmacies.

Inhalation Solution

Drugs.com Printable Discount Card

The free Drugs.com Discount Card works like a coupon and can save you up to 80% or more off the cost of prescription medicines, over-the-counter drugs and pet prescriptions.

Print Free Discount Card

Please note: This is a drug discount program, not an insurance plan. Valid at all major chains including Walgreens, CVS Pharmacy, Target, WalMart Pharmacy, Duane Reade and 65,000 pharmacies nationwide.

Yupelri Coupons and Rebates

Yupelri offers may be in the form of a printable coupon, rebate, savings card, trial offer, or free samples. Some offers may be printed right from a website, others require registration, completing a questionnaire, or obtaining a sample from the doctor's office.

Yupelri Savings Card: Eligible commercially insured patients may pay as little as $0 with a maximum savings of up to $550 per 30-day prescription; maximum savings of $6600 per calendar year; for additional information contact the program at 866-255-9018.

Applies to:
Yupelri
Number of uses:
12 times within calendar year

More information please phone: 866-255-9018 Visit Website

Patient Assistance Programs for Yupelri

Patient assistance programs (PAPs) are usually sponsored by pharmaceutical companies and provide free or discounted medicines to low income or uninsured and under-insured people who meet specific guidelines. Eligibility requirements vary for each program.

There are currently no Patient Assistance Programs that we know about for this drug.